EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY 4.0

Evaluation of the Rational Use of Broad-Spectrum Antibiotics According to Regulatory Guidelines in Hospitalized Patients: A Descriptive Study

Alireza Kananinambani, Majid Shohrati, Mahdi Bagheri, Bita Najafian

Iranian Journal of Pharmaceutical Research · 27.07.2025 · 24 (1)

DOI: 10.5812/ijpr-163289 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Iranian Journal of Pharmaceutical Research, online erschienen am 27.07.2025. Verfasst von Alireza Kananinambani und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Baqiyatallah University of Medical Sciences, Tehran, Iran. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Antimicrobial resistance (AMR) is becoming a serious issue for global health, with predictions of up to 10 million deaths each year by 2050. Antimicrobial stewardship programs (ASPs), supported by WHO, CDC, and various health organizations, are designed to improve antibiotic use through guidelines and reviews.

Objectives

The present study examined adherence to national guidelines for broad-spectrum antibiotics in patients at Baqiyatallah Hospital in Tehran.

Methods

Between November 2024 and March 2025, researchers analyzed 120 hospitalized patients at Baqiyatallah Hospital who were prescribed specific broad-spectrum antibiotics, such as meropenem and vancomycin. They collected information about the patients, lab results, culture findings, and their antibiotic prescriptions.

Results

We found that only 33.3% of patients had a consult from infectious diseases (ID) specialists, and just 30% had their prescriptions reviewed by a pharmacist. Cultures were taken from 87.5% of patients. The ID specialists made continuation/discontinuation decisions in only 4 of 184 cases (2.2%).

Conclusions

Overall, the use of broad-spectrum antibiotics at this hospital often deviates from the recommended guidelines. Involvement from ID teams and routine checks by pharmacists were not utilized as much as needed. These results indicate a clear need to improve ASPs and increase the involvement of clinical pharmacists to encourage better antibiotic use.

Schlagwörter

Stichwörter der Autor:innen

Antimicrobial ResistanceAntimicrobial StewardshipAutomatic Stop OrderBroad-Spectrum AntibioticsHospital EpidemiologyHospital-Acquired InfectionsMicrobial CultureRational Antibiotic Use

Autor:innen und Institutionen

  • Faculty of Pharmacy, Baqiyatallah University of Medical Sciences, Tehran, Iran.
  • Department of Clinical Pharmacy, Faculty of Pharmacy, Baqiyatallah University of Medical Sciences, Tehran, Iran.
  • Department of Pediatrics, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Zitieren

APA

Kananinambani, A., Shohrati, M., Bagheri, M., & Najafian, B. (2025). Evaluation of the Rational Use of Broad-Spectrum Antibiotics According to Regulatory Guidelines in Hospitalized Patients: A Descriptive Study. Iranian Journal of Pharmaceutical Research, 24(1). https://doi.org/10.5812/ijpr-163289

Vancouver

Kananinambani A, Shohrati M, Bagheri M, Najafian B. Evaluation of the Rational Use of Broad-Spectrum Antibiotics According to Regulatory Guidelines in Hospitalized Patients: A Descriptive Study. Iranian Journal of Pharmaceutical Research. 2025;24(1). doi:10.5812/ijpr-163289

BibTeX
@article{Kananinambani2025,
  author = {Kananinambani, Alireza and Shohrati, Majid and Bagheri, Mahdi and Najafian, Bita},
  title = {Evaluation of the Rational Use of Broad-Spectrum Antibiotics According to Regulatory Guidelines in Hospitalized Patients: A Descriptive Study},
  journal = {Iranian Journal of Pharmaceutical Research},
  year = {2025},
  volume = {24},
  number = {1},
  doi = {10.5812/ijpr-163289}
}
Kostenlos starten →